Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Conor launches countersuit against Angiotech:

This article was originally published in Clinica

Executive Summary

Conor Medsystems, the Nasdaq-listed, Menlo Park, California-based developer of drug-eluting stents, has launched legal proceedings in the UK against Canadian firm Angiotech Pharmaceuticals. Conor wants the court to revoke Angiotech's European patent relating to stents coated with paclitaxel and a polymer carrier. Its challenge follows Angiotech's filing of a joint lawsuit with DES partner Boston Scientific against Conor earlier this month, accusing the latter of infringing the patent in question. Vancouver-based Angiotech said it expected Conor to "take various defensive acts", against which it would defend itself "to the fullest".





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts